Xiaodong Wang - 16 Mar 2023 Form 4 Insider Report for BeiGene, Ltd. (BGNE)

Role
Director, Chair, Scientific Advisory Brd
Signature
/s/ Qing Nian, Attorney-in-Fact
Issuer symbol
BGNE
Transactions as of
16 Mar 2023
Transactions value $
$0
Form type
4
Filing time
20 Mar 2023, 17:37:48 UTC
Previous filing
10 Mar 2023
Next filing
20 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BGNE Ordinary Shares Gift $0 -67.4K -1.22% $0.00 5.45M 16 Mar 2023 Direct F1
holding BGNE Ordinary Shares 1.13M 16 Mar 2023 See Footnote F2
holding BGNE Ordinary Shares 172K 16 Mar 2023 See Footnote F3
holding BGNE Ordinary Shares 4.06M 16 Mar 2023 See Footnote F4
holding BGNE Ordinary Shares 50 16 Mar 2023 See Footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Bona fide gift(s) of shares which are exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16b-5.
F2 These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.
F3 These securities are held in a UTMA account for the Reporting Person's child, for which the Reporting Person disclaims beneficial ownership.
F4 These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.
F5 These securities are held by the spouse of the Reporting Person.